Open AccessE1912 Trial Leads to Approval of Ibrutinib-Rituximab Combo for CLL
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000668172.33919.96
Subject(s) - ibrutinib , rituximab , medicine , oncology , chronic lymphocytic leukemia , leukemia , lymphoma